Blood-based Biomarker For Alzheimer's Disease Diagnostics Market Growth is booming worldwide Analysis By FMI
In a landscape where the global burden of Alzheimer's disease continues to escalate, the emergence of blood-based biomarkers is heralding a new era of accessible, early detection. The blood-based biomarker for Alzheimer's disease diagnostics market is on track for remarkable expansion, forecasted to grow from USD 160.8 million in 2025 to an impressive USD 654.4 million by 2035. This...
0 Commentarii 0 Distribuiri 79 Views